Table III.
SNP | Genotype | OR (95% CI) | P-value |
---|---|---|---|
VDR | |||
rs731236 | CC | 2.54 (0.18–7.26) | 0.41 |
CT | 0.47 (0.16–1.36) | 0.13 | |
TT | 1.67 (0.67–4.48) | 0.25 | |
rs15444410 | AA | 0.31 (0.01–2.98) | 0.26 |
GA | 0.95 (0.46–1.92) | 0.89 | |
GG | 1.20 (0.60–2.38) | 0.58 | |
rs2228570 | TT | 2.30 (1.14–4.69) | 0.01 |
CT | 0.63 (0.36–1.09) | 0.08 | |
CC | 0.93 (0.51–1.69) | 0.80 | |
TNFSF11 | |||
rs9533155 | GG | 0.74 (0.31–1.75) | 0.46 |
CG | 1.29 (0.75–2.23) | 0.33 | |
CC | 0.87 (0.50–1.53) | 0.61 | |
rs9533156 | CC | 0.75 (0.33–1.67) | 0.44 |
CT | 1.31 (0.76–2.27) | 0.30 | |
TT | 0.85 (0.49–1.54) | 0.60 | |
rs9525641 | CC | 0.96 (0.41–2.20) | 0.91 |
CT | 1.24 (0.72–2.15) | 0.41 | |
TT | 0.80 (0.45–1.43) | 0.43 |
OR, odds ratio; CI, confidence interval; SNP, single nucleotide polymorphism; VDR, vitamin D receptor; TNFSF11, tumor necrosis factor superfamily member 11.